DocDollars

Pharmaessentia USA Corporation

MA · United States · Reporting entity ID 100001176899

Total reported 2019–2025
$14.9M
#393 of 2,960 reporting companies — 0% of all reported industry payments
$2.59M in general payments across 16,455 records, plus $12.3M in research funding across 979 records.

How it breaks down

General payments $2,586,455
Research funding $12,277,146

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Pharmaessentia USA Corporation reported $14.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #393 of 2,960 reporting companies. 83% of that was research funding and 17% general payments such as consulting, speaking, food and travel. 16,455 general payment records and 979 research records were filed.

Common questions about Pharmaessentia USA Corporation

How much has Pharmaessentia USA Corporation paid US doctors?

Pharmaessentia USA Corporation reported $14,863,600 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,586,455 in general payments, $12,277,146 in research funding.

How does Pharmaessentia USA Corporation rank among drug and device companies?

It ranks #393 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Pharmaessentia USA Corporation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.